BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 12, 2015
View Archived Issues
Immuron and Immune Biologics sign agreement on IMM-124-E for alcohol toxicity
Read More
OncoMed doses first patient in phase I trial of OMP-305B83
Read More
ProNAi begins phase II trial of PNT-2258 in diffuse large B-cell lymphoma
Read More
Azacytidine modulates lenalidomide cytotoxicity in the treatment of B-cell lymphoma
Read More
Galapagos begins phase II trial of GLPG-1205 in ulcerative colitis
Read More
Cardio3 BioSciences acquires Celdara Medical's OnCyte immuno-oncology cell therapy business
Read More
23andMe and Genentech to analyze genomic data for Parkinson's disease
Read More
New proteasome inhibitors show efficacy in vitro and in vivo
Read More
FDA approves SynCardia Total Artificial Heart for destination therapy study
Read More
Alexion reports results from phase II trial of eculizumab in prevention of transplant rejection
Read More
Newly described PIEZO1 mutation causes hereditary xerocytosis
Read More
FDA awards QIDP designation to Achaogen's plazomicin
Read More
Lytix Biopharma discloses novel kinase inhibitors
Read More
Janssen patents novel BACE inhibitors
Read More
4SC Discovery patent reports new DURK1B inhibitors for cancer
Read More
New BRD4 inhibitors designed by Bayer
Read More
Scientists at MyoKardia prepares novel agents for cardiomyopathy
Read More
CytRx reports interim phase II aldoxorubicin data in HIV-related Kaposi's sarcoma
Read More
Infinity Pharmaceuticals reports topline data from phase II duvelisib trial in RA
Read More
EMA accepts alirocumab MAA for review
Read More
Shire to acquire NPS Pharmaceuticals
Read More
Chimerix updates status of brincidofovir development
Read More
Biogen Idec discloses phase II trial results for BIIB-033 in acute optic neuritis
Read More
BTG acquires PneumRx
Read More
Argos Therapeutics reports results from phase IIb trial of AGS-004 in HIV-1 infection
Read More